Literature DB >> 15081261

Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham's chorea patients.

Antonio L Teixeira1, Francisco Cardoso, Adriano L S Souza, Mauro M Teixeira.   

Abstract

Sydenham's chorea (SC) is thought to result from the action of streptococcus-induced antibodies that cross react with basal ganglia antigens. Much less is known, however, about the involvement of cellular mechanisms in its pathogenesis. Since chemokines seem to play a role in several CNS inflammatory disorders, we sought to investigate the chemokine profile of patients with SC. Increased serum levels of CXCL9, formerly monokine induced by interferon-gamma (Mig), and CXCL10, formerly interferon-gamma-inducible protein of 10 kDa (IP-10) were demonstrated in acute SC patients, suggesting that a particular group of chemokines may be involved in SC pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081261     DOI: 10.1016/j.jneuroim.2004.01.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Psychosis following acute Sydenham's chorea.

Authors:  Antônio Lúcio Teixeira; Débora Palma Maia; Francisco Cardoso
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-06-20       Impact factor: 4.785

2.  Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.

Authors:  J B Guerreiro; S B Santos; D J Morgan; A F Porto; A L Muniz; J L Ho; A L Teixeira; M M Teixeira; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Authors:  Paulo R Machado; Maria Elisa A Rosa; Diego Costa; Moema Mignac; João S Silva; Albert Schriefer; Mauro M Teixeira; Olivia Bacellar; Edgar M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-02       Impact factor: 2.184

4.  Serum levels of brain-derived neurotrophic factor in Sydenham's chorea.

Authors:  Antônio Lúcio Teixeira; Thales Lage Bretas; Arthur Kummer; Lívia Cunha Melo; Amanda Baraldi; Estefânia Harsányi; Francisco Cardoso; Elizabeth Ribeiro da Silva Camargos
Journal:  Neurol Sci       Date:  2010-01-29       Impact factor: 3.307

5.  Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease.

Authors:  Mercedes Gonzalez-Juarrero; Luke C Kingry; Diane J Ordway; Marcela Henao-Tamayo; Marisa Harton; Randall J Basaraba; William H Hanneman; Ian M Orme; Richard A Slayden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

6.  CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors.

Authors:  Tyler Cutforth; Mellissa Mc DeMille; Ilir Agalliu; Dritan Agalliu
Journal:  Future Neurol       Date:  2016-12

7.  Increased interictal serum levels of CXCL8/IL-8 and CCL3/MIP-1α in migraine.

Authors:  Halina Duarte; Antonio L Teixeira; Natália P Rocha; Renan B Domingues
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

8.  Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder.

Authors:  Satyajit Mohite; Hanjing Wu; Shiva Sharma; Luca Lavagnino; Cristian P Zeni; Terrence T Currie; Jair C Soares; Teresa A Pigott
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.